Case Report
Multifocal ERG Guiding Therapy in a Case of Hydroxychloroquine Premaculopathy
Table 1
P1 amplitudes (nv/deg2) follow-up.
| | | 4 months | 18 months | 25 months | 34 months | | | RE | LE | RE | LE | RE | LE | RE | LE |
| | Ring 1 | 38.7 | 28.2 | 41.4 | 32.1 | 41.9 | 43.8 | 49.1 | 40.9 | | Ring 2 | 22.1 | 19.3 | 23.8 | 20.3 | 23.2 | 23.4 | 27.3 | 22.7 | | Ring 3 | 13.5 | 11.9 | 13.1 | 12.2 | 13.3 | 12.4 | 14.4 | 13.3 | | Ring 4 | 10.0 | 8.2 | 9.4 | 9.1 | 8.9 | 8.6 | 9.3 | 9.1 | | Ring 5 | 8.6 | 8.0 | 8.2 | 7.7 | 7.7 | 7.7 | 7.8 | 7.3 |
|
|
Values below normal [8]; versus 4 months, Student’s -test; LE: left eye. RE: right eye.
|
